Transgene SA
Symbol: 0OCQ.L
LSE
1.248
EURMarktpreis heute
-3.7467
P/E-Verhältnis
-2.5478
PEG-Verhältnis
135.28M
MRK Kapital
- 0.00%
DIV Rendite
Transgene SA (0OCQ-L) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 15.7 | 26.8 | 49.6 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 22.4 | 43.7 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 1.5 | 3.7 | 11.3 | ||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 0.9 | 16 | 1.4 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 18 | 46.5 | 62.2 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 12.3 | 11.2 | 11.3 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 1.3 | 1.7 | 20.8 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 13.5 | 7 | 7.4 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 27.2 | 19.9 | 39.6 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 45.2 | 66.4 | 101.8 | ||||||||||||
balance-sheet.row.account-payables | 0 | 4.5 | 7 | 7.7 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 1.2 | 1.2 | 1.3 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 16 | 12.3 | 15.2 | ||||||||||||
Deferred Revenue Non Current | 0 | 12.9 | 0 | 0 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 4.2 | 3.6 | 4.6 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 16.5 | 4.7 | 7.3 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 1.3 | 2.4 | ||||||||||||
balance-sheet.row.total-liab | 0 | 26.5 | 17.5 | 21.9 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 50.4 | 50.1 | 48.9 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | -105.8 | -83.4 | -50.6 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -0.2 | 0.4 | 1.5 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 71.2 | 70.8 | 67.4 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 15.6 | 37.8 | 67.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 45.2 | 66.4 | 101.8 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 0 | 15.6 | 37.8 | 67.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 1.3 | 24.1 | 64.4 | ||||||||||||
balance-sheet.row.total-debt | 0 | 1.3 | 2.4 | 3.7 | ||||||||||||
balance-sheet.row.net-debt | 0 | -14.4 | -2 | -2.2 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -22.3 | -32.8 | -19.5 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1.6 | 1.7 | 2.5 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -10 | 3.1 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 2.7 | 4.7 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -7.1 | 5.1 | -12.8 | ||||||||||||
cash-flows.row.account-receivables | 0 | -3.8 | 7.1 | -14.8 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.account-payables | 0 | -2.5 | -0.8 | 2.7 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -0.8 | -1.3 | -0.7 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | -7.2 | 12.4 | -10 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2.7 | -1.5 | -0.7 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 37.3 | 21.8 | 17.5 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 34.6 | 20.3 | 16.8 | ||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -1.3 | -0.2 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 33.3 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 12.9 | 0.5 | -15.9 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 11.7 | -0.8 | 15.9 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | 11.3 | -1.5 | 0.6 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 15.7 | 4.4 | 5.9 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 4.4 | 5.9 | 5.3 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | -35 | -20.9 | -32.1 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -2.7 | -1.5 | -0.7 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | -37.7 | -22.5 | -32.8 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1.2 | 3.1 | 10 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 29.6 | 32.2 | 32.9 | ||||||||||||
income-statement-row.row.gross-profit | 0 | -28.4 | -29 | -22.9 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 35 | 38.4 | 37.7 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 36.6 | 40.1 | 40.3 | ||||||||||||
income-statement-row.row.interest-income | 0 | 7.7 | 0.3 | 0.1 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0.8 | 0.5 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 6.6 | -2.7 | 3.7 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 6.6 | -2.7 | 3.7 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0.8 | 0.5 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1.6 | 1.7 | 2.5 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | -35.4 | -37 | -30.3 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | -28.8 | -39.6 | -26.5 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | -6.5 | -6.8 | -7 | ||||||||||||
income-statement-row.row.net-income | 0 | -22.3 | -32.8 | -19.5 |
Häufig gestellte Frage
Wie hoch ist die Transgene SA (0OCQ.L) Gesamtvermögen?
Transgene SA (0OCQ.L) Gesamtvermögen ist 45217000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist -4.763.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -0.561.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -6.524.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -9.816.
Was ist der Transgene SA (0OCQ.L) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -22328000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 1257000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 34989000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.